Skip to main content
SpringerLink
Log in

Prognostic factors of anaplastic thyroid carcinoma

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Background and purpose: Anaplastic thyroid carcinoma (ATC) is one of the most aggressive malignancies. We tried to elucidate the possible prognostic factors. Methods: A retrospective review was conducted of ATC patients in National Taiwan University Hospital from 1978 to 2003. Their demographic characteristics, clinical presentations, laboratory data and treatment modalities were reviewed. Possible prognostic factors for survival were evaluated. Results: Forty-five patients (14 males and 31 females) of mean age 61.9±12.6 yr were included in this study. The median survival time was 94 days (range 6 to 776 days). The overall survival rate was 27% at 6 months and 10% at 1 yr. Thirty-two patients receiving intervention regimens had a median survival of 106 days, while 13 patients receiving palliative therapy had a median survival of 39 days. The difference in survival is statistically significant (logrank test, p=0.017). Adjusted with sex and age, increment in white blood cell count (per 109/l) and serum albumin (per1.0 g/l) had a hazard ratio of 1.12 (Cox regression, p<0.001) and 0.92 (p=0.041), respectively. Patients with leukocytosis [white blood cell (WBC) count >1010/l] or hypoalbuminemia (serum albumin <35 g/l) had significant shorter survival than patients without leukocytosis or hypoalbuminemia (logrank test p=0.008 and p=0.032, respectively). Patients with serum T4 levels lower than 64.35 nmol/l had significantly shorter survival than patients without hypothyroxinemia (median survival 24 vs 128 days, logrank test, p=0.004). Conclusions: ATC is an aggressive malignancy. Leukocytosis, hypoalbu-minemia and hypothyroxinemia indicated poor prognosis. Survival time might be prolonged if intervention treatment is tolerable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Figge J. Epidemiology of thyroid cancer. In: Wartofsky L. ed. Thyroid Cancer: a comprehensive guide to clinical management. Totowa: Humana Press. 1999, 77–83.

    Google Scholar 

  2. Demeter JG, DeJong SA, Lawrence AM, Paloyan E. Anaplastic thyroid carcinoma: risk factors and outcome. Surgery 1991, 110: 956–63.

    PubMed  CAS  Google Scholar 

  3. Tan RK, Finley RK 3rd, Driscoll D, Bakamijan V, Hicks WL Jr, Shedd D P. Anaplastic carcinoma of the thyroid: a 24-year experience. Head Neck 1995, 17: 41–7.

    Article  PubMed  CAS  Google Scholar 

  4. Tobler A, Maurer R, Hedinger CE. Undifferentiated thyroid tumors of diffuse small cell type. Virchows Arch A Pathol Anat Histopathol 1984, 404: 117–26.

    Article  PubMed  CAS  Google Scholar 

  5. Myskow MW, Krajewski AS, Dewar AE, Millar EP, McLaren K, Fabre JW. The role of immunoperoxidase techniques on paraffin-embedded tissue in determining the histogenesis of undifferentiated thyroid neoplasms. Clin Endocrinol (Oxf) 1986, 24: 335–41.

    Article  CAS  Google Scholar 

  6. Holting T, Moller P, Tschahargane C, Meybier H, Buhr H, Herfarth C. Immuno-histochemical reclassification of anaplastic thyroid carcinoma reveals small and giant cell lymphoma. World J Surg 1990, 14: 291–5.

    Article  PubMed  CAS  Google Scholar 

  7. Ain KB. Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches. Thyroid 1998, 8: 715–26.

    Article  PubMed  CAS  Google Scholar 

  8. Bakiri F, Djemli FK, Mokrane LA, Djidel FK. The relative roles of endemic goiter and socioeconomic development status in the prognosis of thyroid carcinoma. Cancer 1998, 82: 1146–53.

    Article  PubMed  CAS  Google Scholar 

  9. Ain KB. Anaplastic thyroid carcinoma: a therapeutic challenge. Semin Surg Oncol 1999, 16: 64–9.

    Article  PubMed  CAS  Google Scholar 

  10. Hadar T, Mor C, Shvero J, Levy R, Segal K. Anaplastic carcinoma of the thyroid. Eur J Surg Oncol 1993, 19: 511–6.

    PubMed  CAS  Google Scholar 

  11. Agrawal S, Rao RS, Parikh EM, Parikh HK, Borges AM, Sampat MB. Histologic trends in thyroid cancer 1969–1993: A clinico-pathologic analysis of the relative proportion of anaplastic carcinoma of the thyroid. J Surg Oncol 1996, 63: 251–5.

    Article  PubMed  CAS  Google Scholar 

  12. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. A population based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973–1991. Cancer 1997, 79: 564–73.

    CAS  Google Scholar 

  13. Carty SE. Anaplastic thyroid cancer. In: Surgical Endocrinology, 1st ed. Doherty G, Skogeid B eds. Philadelphia: Lippincott Williams & Wilkin. 2001, 127–34.

    Google Scholar 

  14. Nel CJ, van Heerden JA, Goellner JR, et al. Anaplastic carcinoma of thyroid: a clinicopathologic study of 82 cases. Mayo Clin Proc 1985, 60: 51–8.

    Article  PubMed  CAS  Google Scholar 

  15. Venkatesh YS, Ordonez NG, Schultz PN, Hickey RC, Geopfert H, Samaan NA. Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer 1990, 66: 321–30.

    CAS  Google Scholar 

  16. Pasieka JL. Anaplastic thyroid cancer. Curr Opin Oncol 2003, 15: 78–83.

    Article  PubMed  Google Scholar 

  17. Carcangiu ML, Steeper T, Zampi G, Rosai J. Anaplastic thyroid carcinoma: A study of 70 cases. Am J Clin Pathol 1985, 83: 135–58.

    PubMed  CAS  Google Scholar 

  18. Passler C, Scheuba C, Prager G, et al. Anaplastic (undiffer-entiated) thyroid carcinoma (ATC). Langenbecks Arch Surg 1999, 384: 284–93.

    Article  PubMed  CAS  Google Scholar 

  19. American Joint Committee on Cancer. In: Fleming ID, et al. eds. American Joint Committee on Cancer manual for staging of cancer, 5th ed. Philadelphia: Lippincott-Raven 1997.

  20. Nilsson O, Lindeberg J, Zedenius J, et al. Anaplastic giant cell carcinoma of the thyroid gland: treatment and survival over a 25-year period. World J Surg 1998, 22: 725–30.

    Article  PubMed  CAS  Google Scholar 

  21. Rosai J, Saxen EA, Woolner L. Session III. Undifferentiated and poorly differentiated carcinoma. Semin Diagn Pathol 1985, 2: 123–36.

    CAS  Google Scholar 

  22. Sniezek JC, Holtel M. Rare tumors of the thyroid gland. Otolaryngol Clin North Am 2003, 36: 107–15.

    Article  PubMed  Google Scholar 

  23. Samaan NA, Ordonez NG. Uncommon types of thyroid cancer. Endocrinol Metab Clin North Am 1990, 19: 637–48.

    PubMed  CAS  Google Scholar 

  24. Wolf BC, Sheahan K, DeCoste D, Variakojis D, Alpern HD, Haselow RE. Immunohistochemical analysis of small cell tumors of the thyroid gland: an Eastern Cooperative Oncology Group study. Hum Pathol 1992, 23: 1252–61.

    Article  PubMed  CAS  Google Scholar 

  25. Mclver B, Hay ID, Giuffrida D, et al. Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery 2001, 130: 1028–34.

    Article  Google Scholar 

  26. Junor EJ, Paul J, Reed NS. Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy. Eurp J Surg Oncol 1992, 18: 83–8.

    CAS  Google Scholar 

  27. Burman KD, Ringel MD, Wartofsky L. Unusual types of thyroid neoplasms. Endocrinol Metab Clin North Am 1996, 25: 49–68.

    Article  PubMed  CAS  Google Scholar 

  28. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995. Cancer 1998, 83: 2638–48.

    Article  PubMed  CAS  Google Scholar 

  29. Lo CY, Lam KY, Wan KY. Anaplastic carcinoma of thyroid. Am J Surg 1999, 177: 337–9.

    Article  PubMed  CAS  Google Scholar 

  30. Chang TC, Liaw KY, Kuo SH, Chang CC, Chen FW. Anaplastic thyroid carcinoma: Review of 24 cases, with emphasis on cytodiagnosis and leukocytosis. J Formosan Med Assoc 1989, 88: 551–6.

    CAS  Google Scholar 

  31. Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. Prognostic factors and therapeutic strategy for anaplastic thyroid carcinoma of the thyroid. World J Surg 2001, 25: 617–22.

    Article  PubMed  CAS  Google Scholar 

  32. Dinarello CA, Cannon JG, Wolff SM, et al. Tumor necrosis factors (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986, 163: 1433–50.

    Article  PubMed  CAS  Google Scholar 

  33. Klebanoff SJ, Vadas MA, Harlan JM, et al. Stimulation of neutrophils by tumor necrosis factor. J Immunol 1986, 136: 4220–5.

    PubMed  CAS  Google Scholar 

  34. Zucali JR, Dinarello CA, Oblon DJ, Gross MA, Anderson L, Weiner RS. Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J Cin Invest 1986, 77: 1857–63.

    Article  CAS  Google Scholar 

  35. Oppencheim A, Miller M, Anderson GH, Davis B, Slagle T. Anaplastic thyroid cancer presenting with hyperthyroidism. Am J Med 1983, 75: 702–4.

    Article  Google Scholar 

  36. Murakami T, Noguchi S, Murakami N, Tajiri J, Ohta Y. Destructive thyrotoxicosis in a patient with anaplastic thyroid cancer. Endocrinol Jpn 1989, 36: 905–7.

    Article  PubMed  CAS  Google Scholar 

  37. Alagol F, Tanakol R, Boztepe H, Kapran Y, Terzioglu T, Dizdaroglu F. Anaplastic thyroid cancer with transient thyrotoxicosis: case report and literature review. Thyroid 1999, 9: 1029–32.

    Article  PubMed  CAS  Google Scholar 

  38. Basaria S, Udelsman R, Tejedor-Sojo J, Westra WH, Krasner AS. Anaplastic pseudothyroiditis. Clin Endocrinol (Oxf) 2002, 56: 553–5.

    Article  Google Scholar 

  39. Francis SG, David GG. Basic & Clinical Endocrinology, 7th ed. Lange Medical Books/McGraw-Hill. 2004, 215–29.

  40. Kobayashi T, Asakawa H, Umeshita K, et al. Treatment of 37 patients with anaplastic thyroid carcinoma of the thyroid. Head Neck 1996, 18: 36–41.

    Article  PubMed  CAS  Google Scholar 

  41. Giuffrida D, Gharib H. Anaplastic thyroid carcinoma: current diagnosis and treatment. Ann Oncol 2000, 11: 1083–9.

    Article  PubMed  CAS  Google Scholar 

  42. Tennvall J, Lundell G, Hallquist A, et al. Combined doxorubicin, hyperfractionated radiotherapy and surgery in anaplastic thyroid carcinoma. Report on two protocols. The Swedish Anaplastic Thyroid Cancer Group. Cancer 1994, 74: 1348–54.

    CAS  Google Scholar 

  43. Haigh PI, Ituarte PH, Wu HS, et al. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer 2001, 91: 2335–42.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei County

    J.-Y. Jiang

  2. Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, No. 7, Chung-Shan South Road, Taipei, Taiwan

    F.-Y. Tseng MD, MPH

Authors
  1. J.-Y. Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F.-Y. Tseng MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F.-Y. Tseng MD, MPH.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jiang, JY., Tseng, FY. Prognostic factors of anaplastic thyroid carcinoma. J Endocrinol Invest 29, 11–17 (2006). https://doi.org/10.1007/BF03349171

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349171

Key-words

Search

Navigation